Primolut N vs Provera: Uses, Dosage, Safety, and Clinical Application
- Mayta
- May 26
- 2 min read
Overview
Primolut N (Norethisterone) and Provera (Medroxyprogesterone acetate) are synthetic progestins used in managing a variety of gynecological and endocrine conditions, especially menstrual irregularities. These medications help in restoring hormonal balance, especially when endogenous progesterone levels are insufficient.
1. Drug Profiles
1.1 Primolut N (Norethisterone) 5 mg
Therapeutic Use:
Delay of menstruation
Dysfunctional uterine bleeding (DUB)
Endometriosis
Polycystic ovary syndrome (PCOS)-related cycle irregularities
Premenstrual syndrome (PMS)
Dosage:
1 tablet (5 mg) twice daily (1×2 po pc) for 10 days
Mechanism of Action:
Synthetic analog of natural progesterone
Inhibits ovulation when administered in the luteal phase
Stabilizes the endometrium and suppresses abnormal uterine bleeding
1.2 Provera (Medroxyprogesterone Acetate) 5 mg
Therapeutic Use:
Secondary amenorrhea
Menstrual cycle regulation
Hormone Replacement Therapy (HRT) adjunct
Management of abnormal uterine bleeding
Dosage:
1 tablet (5 mg) twice daily (1×2 po pc) for 10 days
Mechanism of Action:
Binds to progesterone receptors, modifying the transcription of target genes
Promotes secretory changes in the endometrium
Suppresses gonadotropin secretion, preventing ovulation
2. Clinical Application in Practice
OPD Prescription Format:
Primolut N (5 mg) 1×2 po pc × 10 days Provera (5 mg) 1×2 po pc × 10 days Follow-up after medication course to assess withdrawal bleeding
IPD Medication Order Format:
Date | Drug | Dose | Route | Frequency | Duration | Instructions |
Today | Primolut N | 5 mg | po | bid pc | 10 days | After meals |
Today | Provera | 5 mg | po | bid pc | 10 days | After meals |
3. Patient Education
3.1 How to Take
Take after meals (po pc) to minimize gastrointestinal side effects.
Maintain consistency in timing (e.g., 8 am and 8 pm) for steady hormone levels.
3.2 Monitoring and Compliance
Maintain a menstrual diary: note timing of menstruation, spotting, and any missed doses.
If menstruation does not occur after medication cessation, consult a physician.
3.3 Side Effects
Common:
Nausea
Headaches
Breast tenderness
Mood swings
Less Common:
Breakthrough bleeding
Bloating
Weight gain
Severe (Seek Immediate Medical Attention):
Chest pain or shortness of breath (risk of thromboembolism)
Visual disturbances
Severe headache or neurological symptoms
4. Special Considerations and Safety
Not a contraceptive: Recommend additional contraception if pregnancy prevention is needed.
Use cautiously in:
History of venous thromboembolism (VTE)
Liver disease or hepatic tumors
Hormone-sensitive cancers (e.g., breast cancer)
Requires baseline assessment if prolonged use is anticipated:
Liver function tests (LFTs)
Clotting profile (if VTE risk)
Pregnancy test if indicated
5. Conclusion
Both Primolut N and Provera play essential roles in managing hormone-related gynecological disorders. When used appropriately with clear instructions and close monitoring, they effectively regulate menstrual cycles, control abnormal bleeding, and support reproductive health. Ensuring patient education, understanding the risk profiles, and correct documentation in both OPD and IPD settings are key to maximizing therapeutic success.
Comments